Literature DB >> 15238871

[Functional and early evaluation of treatments in oncology: interest of ultrasonographic contrast agents].

N Lassau1, M Lamuraglia, J Leclère, V Rouffiac.   

Abstract

The early and functional evaluation of new treatments in oncology is a main goal. At present, technical advances in Doppler-ultrasonography allow the detection of neovascularization for superficial and deep malignant tumors in order to evaluate the efficiency of new treatments as Treatment response can be early predicted according to modifications of this vascularization before Volume modification. Contrast agents injection improves the efficiency of this technique and developments in perfusion softwares optimize this detection.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15238871     DOI： 10.1016/s0221-0363(04)97651-2

Source DB:  PubMed          Journal:  J Radiol        ISSN： 0221-0363


  7 in total

1.  Accuracy of core-needle biopsy after contrast-enhanced ultrasound in soft-tissue tumours.

Authors:  Armanda De Marchi; Elena Maria Brach del Prever; Alessandra Linari; Simona Pozza; Lucia Verga; Ugo Albertini; Marco Forni; Gian Carlo Gino; Alessandro Comandone; Adalberto Maria Brach del Prever; Raimondo Piana; Carlo Faletti
Journal:  Eur Radiol       Date:  2010-06-27       Impact factor: 5.315

Review 2.  Assessment of clinical and radiological response to sorafenib in hepatocellular carcinoma patients.

Authors:  Rodolfo Sacco; Valeria Mismas; Antonio Romano; Marco Bertini; Michele Bertoni; Graziana Federici; Salvatore Metrangolo; Giuseppe Parisi; Emanuele Tumino; Giampaolo Bresci; Luca Giacomelli; Sara Marceglia; Irene Bargellini
Journal:  World J Hepatol       Date:  2015-01-27

3.  Dynamic contrast-enhanced ultrasonography (D-CEUS) for the early prediction of bevacizumab efficacy in patients with metastatic colorectal cancer.

Authors:  Michele Amadori; Domenico Barone; Emanuela Scarpi; Devil Oboldi; Elena Amadori; Gianfranco Bandi; Alice Rossi; Fabio Ferroni; Angela Ragazzini; Andrea Casadei Gardini; Giovanni Luca Frassineti; Giampaolo Gavelli; Alessandro Passardi
Journal:  Eur Radiol       Date:  2018-02-07       Impact factor: 5.315

4.  Core needle biopsy of soft tissue tumors, CEUS vs US guided: a pilot study.

Authors:  Alessandro Coran; Antonio Di Maggio; Marco Rastrelli; Enrico Alberioli; Shady Attar; Paolo Ortolan; Carlo Bortolanza; Annalisa Tosi; Maria Cristina Montesco; Elisabetta Bezzon; Carlo Riccardo Rossi; Roberto Stramare
Journal:  J Ultrasound       Date:  2015-02-15

5.  Therapeutic response monitoring after targeted therapy in an orthotopic rat model of hepatocellular carcinoma using contrast-enhanced ultrasound: Focusing on inter-scanner, and inter-operator reproducibility.

Authors:  Hwaseong Ryu; Jung Hoon Kim; Seunghyun Lee; Joon Koo Han
Journal:  PLoS One       Date:  2020-12-23       Impact factor: 3.240

6.  Double contrast-enhanced ultrasonography in preoperative Borrmann classification of advanced gastric carcinoma: comparison with histopathology.

Authors:  Minqiang Pan; Pintong Huang; Shiyan Li; Jian Chen; Shumei Wei; Ying Zhang
Journal:  Sci Rep       Date:  2013-11-26       Impact factor: 4.379

7.  Famitinib in combination with concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 1, open-label, dose-escalation Study.

Authors:  Qiuyan Chen; Linquan Tang; Na Liu; Feng Han; Ling Guo; Shanshan Guo; Jianwei Wang; Huai Liu; Yanfang Ye; Lu Zhang; Liting Liu; Pan Wang; Yingqin Li; Qingmei He; Xiaoqun Yang; Qingnan Tang; Yang Li; YuJing Liang; XueSong Sun; Chuanmiao Xie; Yunxian Mo; Ying Guo; Rui Sun; Haoyuan Mo; Kajia Cao; Xiang Guo; Musheng Zeng; Haiqiang Mai; Jun Ma
Journal:  Cancer Commun (Lond)       Date:  2018-11-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.